Single Dose Pharmacokinetics of Egalet® Oxycodone
Single Dose Pharmacokinetics of Egalet® Oxycodone
The purpose of the study is to evaluate the pharmacokinetic profile of different Egalet®
 oxycodone formulations and compare to a marketed oxycodone product.
Main inclusion criteria:

 -  ≥18 years and ≤55 years

 -  Non-smoker

 -  BMI ≥18.0 and ≤30.0

 Main exclusion criteria:

 -  Any clinically significant abnormality or abnormal laboratory test results found
 during medical screening

 -  History of allergic reactions to opioids or other related drugs

 -  History of significant alcohol abuse or drug abuse

 -  Use of any drugs known to inhibit hepatic drug metabolism

 -  Pregnant or breast-feeding